欧洲 · 区域市场 · This is Money
Glaxo shares slump amid concerns over its vaccine pipeline of new drugs as patent losses loom
The pharmaceutical giant reported beat third-quarter sales and profit expectations, driven by a 15% rise in demand for its specialty HIV and respiratory medicines.
在 This is Money 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.thisismoney.co.uk)
